Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent
11/03/2026 09:59
March 11 (Reuters) - Elicera Therapeutics AB ELIC.ST: RECEIVES NOTICE OF ALLOWANCE FOR JAPANEASE PATENT PROTECTING THE ELC-401 CAR T-CELL CANDIDATE ONCE PATENT HAS BEEN GRANTED, IT CAN BE MAINTAINED IN FORCE UNTIL 2041 Source text: ID:nWkrnR9KH Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application